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ABSTRACT 
 
Aqueous extract of barley was found to inhibit PG endoperoxide synthase and lipoxygenase 
enzymes responsible for arachidonic acid metabolism. Only 6% (v/v) of aqueous extract produced 
50% inhibition of PG endoperoxide synthase while five times more extract was requited to produce 
50% inhibition of lipoxygenase. Boiling barley extract did not destroy the ability of the extract to 
inhibit the enzymes. Fractionation of barley with organic solvents, petroleum ether, chlorform, 
ethylactate and acetone exhibited selectivity in its action in that foamy layer formed during 
petroleum ether and ethyl acetate extraction inhibited PG endoperoxide synthase completely 
whereas lipoxygenase activity was only partially inhibited. These results suggest the presence of 
inhibitor(s) of arachidonic acid metabolism in extracts of barley. 
 
Introduction 
 
Recently a number of plant products have been under investigation in an effort to 
determine their medicinal value. Inhibitory effects of garlic, onion and ginger on platelet 
aggregation and arachidonic acid (AA) metabolism in animals and humans have been 
reported (Bordia, 1978; Srivastava, 1984; Srivastava, 1984a). Also, a colloidal fraction of 
oats, branded as AVEENO by Knox Laboratories Limited, U.K., has been claimed to 
relieve inflammatory conditions of the skin. In addition, extract of oats has also been 
shown to inhibit PG biosynthesis (Saeed et al; 1981). 
Barley, a plant product obtained from Hordium Vulgate, is widely used as consti-
tuent of cereals (Encyclopedia Britannica, 1980; Encyclopedia Americana, 1985). Its 
medicinal value in urethral inflanunation, jaundice and indigestion is known among 
Asians, though not experimentally established yet. Since effect of barley on AA metabo-
lism has not been studied, we investigated effects of aqueous barley extract and its 
various fractions on AA metabolising enzymes, PG endoperoxide synthase and lipoxyge-
nase. Platelets were taken as a model to measure the activity of PG endoperoxide syn-
thase since this enzyme is present in platelets and leads to the conversion of arachidonic 
acid to PG endoperoxides and thromboxanes; the proaggregatory substances (Harnberg et 
al, 1975; Hammerstrom et al 1980). Lipoxygenase was obtained commercially to study 
the effects of barley. 
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Materials and Methods 
 
Barely seeds were purchased from a local market. Sodium salt of arachidonic acid 
(Type I, 99% pure) and soyabean lipoxygenase were obtained from Sigma, St. Louis, U.S 
A. Ethanol, chloroform petroleum ether, ethylacetate, acetone, sodium phosphate 
(monobasic & dibasic) and sodium carbonate were purchased from E. Merck, Germany. 
Solution of sodium arachidonate was prepared by dissolving a 10 mg ampoule in 
20 µl of ethanol and diluted with 730 µl of 0.2%; w/v sodium carbonate in nitrogen 
atmosphere. 
 
i) Preparation of aqueous extract of barley: 
 
500 grains of barley seeds were soaked in 1 liter of distilled water for 3 days. After 
3 days the mixture was shaken vigorously, allowed to settle down. Supernatant was 
decanted and evaporated under high pressure rotary evaporator at 55oC. The material left 
behind was thick, brown fluid, that was treated as an extract. 
 
ii) Fractionation of barley: 
 
Step I: 1.5 kg of barley seeds were minced in 5 liters of distilled water and filtered 
through a fine sieve. Filtrate was shaken vigorously and 100 ml was reserved as fraction 
1. Two liters of the filtrate was stored in a refrigerator at 4°C for 18 hours and rest was 
extracted as described in Step II. After 18 hours, the portion kept in the refrigerator was 
decanted slowly to get a clear water fraction leaving insoluble material at the bottom. The 
decanted layer was filtered through a filter paper and 100 ml was numbered fraction 2. 
Rest of the material was reserved for acetone precipitation. The residue was mixed with 2 
litres of distilled water, boiled for 10 minutes and allowed to settle. Supernatant was 
decanted, concentrated by evaporation and kept as fraction 3. The starchy left over was 
stored and later labelled as fraction 14. 
Step II: Reserved material from Step I was subjected to organic extraction. It was 
mixed with an equal amount of petroleum ether, shaken vigorously and separated into 
three layers i.e. etherial, aqueous and foamy. Etherial layer was evaporated to dryness, 
powder redissolved in distilled water and stored as fraction 4. Aqueous layer was 
subjected to extraction again with chloroform. Chloroform layer was separated, 
evaporated to dryness, remaining material redissolved in distilled water and was stored as 
fraction 5. The foamy layer was also evaporated to dryness and residue redissolved in 
distilled water and was stored as fraction 12. The aqueous layer was again extracted with 
ethyl acetate and the three layers were separated. Ethyl acetate was evaporated to 
dryness, residue redissolved in distilled water and stored as fraction 6. The foamy layer 
was evaporated to remove organic traces, redissolved in distilled water and stored as 
fraction 13. An aliquot of 100 ml of aqueous layer was concentrated by evaporation and 
stored as fraction 8. 
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Step III: 300 ml of the remaining aqueous from Step II was mixed with 600 nil of 
acetone, filtered evaporated to dryness residue redissoved in distilled water and stored as 
fraction 7. The precipitate was dissolved in distilled water and stored as fraction 9. 
200 ml aliquot of fraction 2 was also precipitated with acetone and filtered. Filtrate 
was concentrated by evaporation and stored as fraction 10. Residue was dissolved in 
distilled water and stored as fraction 11. 
 
Inhibition of PG endoperoxide synthase: 
 
Platelet rich plasma (PRP) was prepared from human blood drawn from healthy 
volunteers who denied taking any medicine within a week of venepuncture. Blood, to 
which sodium citrate was added, was centrifuged at 250 xg for 20 minutes at room 
temperature. An aliquot of PRP was retained for testing and the remaining was 
centrifuged at 1000 xg for 10 minutes to obtain platelet poor plasma (PPP). Platelet 
counts were performed by phase contrast microscopy. 
To study the effect of barley extract (BE) on PG endoperoxide synthase, platelet 
aggregation was measured in a dual channel Lumi-aggregometer (Model 400, Chronolog, 
USA), using a 0.45 ml PRY. PRP was incubated with BE for 1 minute at 37°C and then 
challenged with sodium arachidonate. The resulting aggregation was recorded for 4 
minutes using a chart recorder and quantified as percent inhibition compared with 
controls. 
 
Inhibition of lipoxygenase: 
 
Oxygen consumption was used as an index of lipoxygenase activity. Effect of 
barley was measured polarographically using Biological oxygen monitor (Model 53), 
Yellow Springs Instrument Co., Ohio USA). A standard assay procedure was developed 
by selecting optimal conditions for oxygen consumption during the oxidation of AA by 
lipoxygenase. BE was incubated for 2 minutes at 37°C in a mixture containing 50 mM 
phosphate buffer (pH 7.4) and 61 pM sodium arachidonate. Assay volume was adjusted 
to 4 ml, A change is saturation of oxygen, by mixture, was recorded after 8 minutes. Con-
trols contained all the reagents except barley extract. 
 
Results and Discussion 
 
Aqueous extract of barley, as outlined in (i) in Methods section, in concentrations 
of 5, 8, and 10% (v/v) inhibited PG endoperoxide synthase (assessed by inhibition of 
platelet aggregation) by 7, 52 and 91% respectively (Fig. 1). Same extract in 
concentration of 10, 20, 30 and 40% (v/v) inhibited lipoxygenase (assessed by oxygen 
consumption) by 12, 30, 51 and 72% respectively. The extract of barley was significantly 
more potent (P < 0.01) in inhibiting PG endoperoxide synthase (IC 50 = 6% v/v) than 
inhibiting lipoxygenase (IC 50 = 29% v/v). It is interesting that after boiling barley 
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extract retained this inhibitory effect with almost the same potency for both the enzymes 
(Fig. 2, fraction No.3). 
 
 
 
Fig. 1. Inhibition of PG endoperoxide synthase and lipoxygenase by aqueous extract of 
Barley. Different amounts of barley extract were incubated with enxymes using methods as 
described in the text. 
 
 A total of 14 fractions were obtained after sequential fractionation with petroleum 
ether, chloroform, ethylacetate and acetone 10% (v/v) of each fraction was used to assess 
the effect on the two enzymes. Table 1 shows an outline of inhibitory action of various 
fractions on PG endoperoxide synthase and lipoxygenase. Inhibition of endoperoxide 
synthase by 99% was exhibited by fractions No. 13 and 14 respectively (Fig. 2). On the 
other hand, fractions No. 8, 9 and 12 inhibited lipoxygenase by 62, 48 and 52% 
respectively (Fig. 2). 
It is evident from our data that 5 times less amount of barley extract is required for 
100% inhibition of PG endoperoxide synthase than needed for 70% inhibition of lipoxy-
genase (Fig. I). This was further confirmed from sequential fractionation of barley. 
Almost 100% inhibition of PG endoperoxide synthase was obtained by fractions No. 13 
and 14 while maximum inhibition achieved for lipoxygenase, by fraction No. 8, was 62% 
(Fig. 2). It is noteworthy that fraction No. 14, which was a starchy leftover, strongly 
inhibited PG endoperoxide synthase. These observations suggest that barley extract 
contains inhibitor(s) that alter AA metabolism. This inhibitor may function as a blocker 
of PG endoperoxide synthase more effectively than that of lipoxygenase. 
At this stage, it is difficult to comment on chemical nature of these indigenous 
inhibitor(s), however, they showed significant water solubility and heat-stability. 
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Fig. 2. Fractionation of aquous extract of barley by organic solvents: Fractions were 
obtained by extracting BE (Aq) in petroleum ether, chloroform, ethyl acetate and acetone using 
methods as described in the text. 
 
Table 1. Effect of barley fractions on AA metabolism 
 
Fraction PG Endoperoxide Lipoxygenase 
# Synthase  
1. 0 ++ 
2. 0 0 
3. ++++ ++++ 
4. 0 0 
5. 0 0 
6. 0 0 
7. 0 0
8. ++ +++ 
9. 0 ++ 
10. a + 
I1. 0 0 
12. 0 +++ 
13. ++++ + 
14. ++++ ++ 
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Further purification and characterization of these inhibitors will reveal the true 
nature of these substances. They may he used as inhibitors of AA metabolism or each 
inhibitor may be applied individually to inhibit the specific enzyme. 
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